Aspirin or amiloride for cerebral perfusion defects in cocaine dependence

Drug and Alcohol Dependence

Volumn 71, Issue 2, 2003, Pages 187-194

  Kosten, Thomas R ^a   Gottschalk, P Christopher ^a   Tucker, Karen ^a   Rinder, Christine S ^a   Dey, Holly M ^a   Rinder, Henry M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amiloride; Aspirin; Clinical trial; Cocaine; Imaging; Pharmacotherapy; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; AMILORIDE; COCAINE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; PLACEBO;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD RHEOLOGY; BRAIN BLOOD FLOW; BRAIN MAPPING; BRAIN PERFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; PARAMETRIC TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; THROMBOCYTE AGGREGATION; VASODILATATION;

EID: 0142012004     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(03)00132-7     Document Type: Article

References (53)

1. Acton P.D., Friston K.J. Statistical parametric mapping in functional neuroimaging: beyond PET and fMRI activation studies [editorial]. Eur. J. Nucl. Med. 25:(7):1998;663-667.
2. Andersson J.L. How to estimate global activity independent of changes in local activity. Neuroimage. 6:(4):1997;237-244.
3. Arndt S., Cizadlo T., O'Leary D., Gold S., Andreasen N.C. Normalizing counts and cerebral blood flow intensity in functional imaging studies of the human brain. Neuroimage. 3:(3 Pt. 1):1996;175-184.
4. Chamorro A., Escolar G., Revilla M., Obach V., Vila N., Reverter J.C., Ordinas A. Ex vivo response to aspirin differs in stroke patients with single or recurrent events: a pilot study. J. Neurol. Sci. 171:1999;110-114.
5. Crivello F., Tzourio N., Poline J.B., Woods R.P., Mazziotta J.C., Mazoyer B. Intersubject variability in functional neuroanatomy of silent verb generation: assessment by a new activation detection algorithm based on amplitude and size information. Neuroimage. 2:(4):1995;253-263.
6. Fessler R.D., Esshaki C.M., Stankewitz R.C., Johnson R.R., Diaz F.G. The neurovascular complications of cocaine. Surg. Neurol. 47:(4):1997;339-345.
7. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders. 1997;New York State Psychiatric Institute, New York.
8. Flores E.D., Lange R.A., Cigarroa R.G., Hills L.D. Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: enhanced vasoconstriction at sites of significant stenoses. J. Am. Coll. Cardiol. 16:1990;74-79.
9. Gibbs J.M., Wise R.J.S., Leenders K.L., Jones T. Evaluation of cerebral perfusion reserve in patients with carotid artery occlusion. Lancet. 11:1984;310-314.
10. Gottschalk P.C., Kosten T.R. Cerebral perfusion defects in combined cocaine and alcohol dependence. Drug Alcohol Depend. 68:2002;95-104.
11. Gottschalk P.C.H., Kosten T.R. Isradipine enhancement of cerebral blood flow in abstinent cocaine abusers with and without chronic perfusion deficits. Am. J. Addict. 11:2002;200-208.
12. Gottschalk C., Beauvais J., Hart R., Kosten T. Cognitive function and cerebral perfusion in cocaine abstinence. Am. J. Psychiatry. 158:(4):2001;540-545.
13. Gullion C.M., Devous M.D. Sr, Rush A.J. Effects of four normalizing methods on data analytic results in functional brain imaging. Biol. Psychiatry. 40:(11):1996;1106-1121.
14. Gum P.A., Kottke-Marchant K., Poggio E.D., Gum H., Welsh P.A., Brooks L., Sapp S.K., Topol E.J. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am. J. Cardiol. 88:2001;230-235.
15. Gur R.C., Gur R.E., Resnick S.M., Skolnick B.E., Alavi A., Reivich M. The effect of anxiety on cortical cerebral blood flow and metabolism. J. Cereb. Blood Flow Metab. 7:(2):1987;173-177.
16. Holman B.L., Carvalho P.A., Mendelson J., Teoh S.K., Nardin R., Hallgring E., Hebben N., Johnson K.A. Brain perfusion is abnormal in cocaine-dependent polydrug users: a study using technetium-99m-HMPAO and ASPECT. J. Nucl. Med. 32:(6):1991;1206-1210.
17. Holman B.L., Garada B., Johnson K.A., Mendelson J., Hallgring E., Teoh S.K., Worth J., Navia B.A. A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex. J. Nucl. Med. 33:(7):1992;1312-1315.
18. Holman B.L., Mendelson J., Garada B., Teoh S.K., Hallgring E., Johnson K.A., Mello N.K. Regional cerebral blood flow improves with treatment in chronic cocaine polydrug users. J. Nucl. Med. 34:1993;723-727.
19. Husain S., Andrews N.P., Mulcahy D., Panza J.A., Quyyumi A.A. Aspirin improves endothelial dysfunction in atherosclerosis. Circulation. 97:(8):1998;716-720.
20. Imran M.B., Kawashima R., Sato K., Kinomura S., Ito H., Koyama M., Goto R., Ono S., Yoshioka S., Fukuda H. Mean regional cerebral blood flow images of normal subjects using technetium-99m-HMPAO by automated image registration. J. Nucl. Med. 39:(1):1998;203-207.
21. Karch S.B. Cocaine. Karch S.B. The Pathology of Drug Abuse. 1993;51-64 CRC Press, Boca Raton, FL.
22. Knop J., Thie A., Fuchs C., Siepmann G., Zeumer H. 99mTc-HMPAO-SPECT with acetazolamide challenge to detect hemodynamic compromise in occlusive cerebrovascular disease. Stroke. 23:(12):1992;1733-1742.
23. Konzen J., Levine S., Garcia J. Vasospasm and thrombus formation as possible mechanism of stroke related to alkaloidal cocaine. Stroke. 26:1995;1114-1118.
24. Kosten T.R. Pharmacotherapy of cerebral ischemia in cocaine dependence. Drug Alcohol Depend. 49:(2):1998;133-144.
25. Kosten T.R., Cheeves C., Palumbo J., Seibyl J.P., Price L.H., Woods S.W. Regional cerebral blood flow during acute and chronic abstinence from combined cocaine-alcohol abuse. Drug Alcohol Depend. 50:1998;187-195.
26. Kugelmass A.D., Oda A., Monahan K., Cabral C., Ware J.A. Activation of human platelets by cocaine. Circulation. 88:1993;876-883.
27. Kuroda S., Kamiyama H., Abe H., Houkin K., Isobe M., Mitsumori K. Acetazolamide test in detecting reduced cerebral perfusion reserve and predicting long-term prognosis in patients with internal carotid artery occlusion. Neurosurgery. 32:1993;912-919.
28. Levine S.P., Towell B.L., Suarez A.M., Knieriem L.K., Harris M.M., George J.N. Platelet activation and secretion associated with emotional stress. Circulation. 71:1985;1129-1134.
29. Madden J.A. The effect of carbon dioxide on cerebral arteries. Pharmacol. Ther. 59:(2):1993;229-250.
30. Madden J.A., Konkol R.J., Keller P.A., Alvarez T.A. Cocaine and benzoylecgonine constrict cerebral arteries by different mechanisms. Life Sci. 56:(9):1995;679-686.
31. McLellan A.T., Luborsky L., Woody G.E., O'Brien C.P. An improved diagnostic evaluation instrument for substance abuse patients: the addiction severity index. J. Nerv. Ment. Dis. 168:1980;26-33.
32. Mena I., Giombetti R., Cody C.K. Acute cerebral blood flow changes with cocaine intoxication [Abstract]. Neurology. 40:(Suppl. 1):1990;179.
33. Noe D.A., Kumor K.M. A pharmacokinetic-pharmacodynamic model of heart rate during cocaine administration in humans. Clin. Pharmacol. Ther. 49:1991;426-432.
34. Noon J.P., Walker B.R., Hand M.F., Webb D.J. Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin. Cardiovasc. Res. 38:(2):1998;480-484.
35. Puscas I., Coltau M., Baican M., Domuta G., Hecht A. Vasodilatory effect of diuretics is dependent on inhibition of vascular smooth muscle carbonic anhydrase by a direct mechanism of action. Drugs Exp. Clin. Res. 25:(6):1999;271-279.
36. Rezkallah S., Mazza J.J., Kloner R.A., Pilemma V., Chang S.H. The effect of cocaine on human platelets. J. Am. Coll. Cardiol. 19:1992;322A.
37. Rinder H.M., Bonan J.L., Rinder C.S., Ault K.A., Smith B.R. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood. 78:1991;1760-1769.
38. Rinder C.S., Student L.A., Bonan J.L., Rinder H.M., Smith B.R. Aspirin does not inhibit adenosine diphosphate-induced platelet alpha granule release. Blood. 82:1993;505-512.
39. Rinder H.M., Ault K.A., Jatlow P.I., Kosten T.R., Smith B.R. Platelet Â-granule release in cocaine users. Circulation. 90:1994;1162-1167.
40. Rogg J., Rutiglino M., Yonas H., Johnson D.W., Pentheny S., Latchaw R. The acetazolamide challenge: imaging techniques designed to evaluate cerebral blood flow reserve. Am. J. Neuroradiol. 10:1989;803-810.
41. Saady J.J., Bowman E.R., Aceto M.D. Cocaine, ecgonine methyl ester, and benzoylecgonine plasma profiles in rhesus monkeys. J. Anal. Toxicol. 19:(7):1995;571-575.
42. Saxena, P., Pavel, D., Quintana, J., Tom, M., Hier, D., 1998.HMPAO-SPECT imaging of the dementias: a new method for enhancing its usefulness using whole volume evaluation and a special scaling. In: Chile. The 28th Annual Meeting of the Society for Neuroscience. (C. C. U.), U. Illinois Medical Center, Los Angeles, CA.
43. Schror K. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin. Thromb. Hemost. 23:1997;349-356.
44. Siffet W., Gengenbach S., Scheid P. Inhibition of platelet aggregation by amiloride. Thromb. Res. 44:1986;235.
45. Stamatakis E.A., Glabus M.F., Wyper D.J., Barnes A., Wilson J.T. Validation of statistical parametric mapping (SPM) in assessing cerebral lesions: a simulation study. Neuroimage. 10:1999;397-407.
46. Strickland T.L., Mena I., Villanueva-Meyer J., Miller B.L., Cummings J., Mehringer C.M., Satz P., Myers H. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J. Neuropsychiatr. Clin. Neurosci. 5:(4):1993;419-427.
47. Tofler G.H., Brezinski D., Schafer A.I., Czeisler C.A., Rutherford J.D., Willich S.N., Gleason R.E., Williams G.H., Muller J.E. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. New Engl. J. Med. 316:1987;1514-1518.
48. Togna G., Tempesta E., Togna A.R., Dolci N., Cebo B., Caprino L. Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment. Haemostasis. 15:1985;100-107.
49. Tumeh S.S., Nagel J.S., English R.J., Moore M., Holman B.L. Cerebral abnormalities in cocaine abusers: demonstration by SPECT perfusion brain scintigraphy. Radiology. 176:1990;821-824. Work in progress.
50. Vitullo J.C., Karam R., Mekhail N., Wicker P., Engelmann G.L., Khairallah P.A. Cocaine-induced small vessel spasm in isolated rat hearts. Am. J. Pathol. 135:1989;85-91.
51. Volkow N.D., Mullani N., Gould L., Adler S., Krajewski K. Cerebral blood flow in chronic cocaine users: a study with positron emission tomography. Br. J. Psychiatry. 152:1988;641-648.
52. Weber D.A., Franceschi D., Ivanovic M., Atkins H.L., Cabahug C., Wong C.T., Susskind H. SPECT and planar brain imaging in crack abuse: iodine-123-iodoamphetamine uptake and localization. J. Nucl. Med. 34:(6):1993;899-907.
53. Woods R.P., Grafton S.T., Holmes C.J., Cherry S.R., Mazziotta J.C. Automated image registration: I. General methods and intrasubject, intramodality validation. J. Comput. Assist. Tomogr. 22:(1):1998;139-152.